|
Volumn 17, Issue 4, 2005, Pages 12-15
|
Efficacy and adverse effects of oral iron chelator deferiprone (l1, 1,2- dimethyl-3-hydroxypyrid-4-one) in patients with beta thalassaemia major in Pakistan.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFERIPRONE;
FERRITIN;
IRON CHELATING AGENT;
PYRIDONE DERIVATIVE;
ADOLESCENT;
ADULT;
ARTICLE;
BETA THALASSEMIA;
BLOOD;
CHILD;
DEMOGRAPHY;
DRUG EFFECT;
FEMALE;
GENETICS;
HUMAN;
MALE;
PAKISTAN;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
BETA-THALASSEMIA;
CHILD;
DEMOGRAPHY;
FEMALE;
FERRITINS;
HUMANS;
IRON CHELATING AGENTS;
MALE;
PAKISTAN;
PROSPECTIVE STUDIES;
PYRIDONES;
TREATMENT OUTCOME;
|
EID: 33646713435
PISSN: 10259589
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|